
Innocan Pharma Announces Closing of Debenture Unit Offering to its Largest Shareholder, Tamar Innovest Limited

Innocan Pharma erhält für seine liposomale CBD-Injektion das erste Patent in Indien
Latest Press release:

Innocan Pharma Announces Closing of Debenture Unit Offering to its Largest Shareholder, Tamar Innovest Limited
NEUESTE PRESSEMITTEILUNG:

Innocan Pharma erhält für seine liposomale CBD-Injektion das erste Patent in Indien
Q3 2024 Financial Statement
Canadian Securities Exchange (CSE)
SYMBOL: INNO
Frankfurt Stock Exchange (FSE)
SYMBOL: FRA – IP4
US Stock Exchange (OTC)
SYMBOL: INNPF
Email us - [email protected]